A suspension of pantoprazole 2 mg/mL was prepared by triturating ... The suspension was transferred to six 3-oz amber polyethylene terephthalate bottles with childresistant caps,d a 3.75-mL ...
The index dropped 2.12% during the session. The Nifty Pharma index ended January with a 9% decline, as weak earnings from major Indian pharmaceutical companies prompted brokerages to lower their ...
Divi’s Labs, Granules, and Aurobindo Pharma also saw losses in the range of 2-3 per cent. Other pharma majors such as Biocon, Zydus Life, Ajanta Pharma, Lupin, and Gland Pharma recorded drops of 2-2.5 ...
LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma Ltd. (NYSE American ... Utah for the Phase 2 clinical trial for ENV105 for castrate-resistant prostate cancer patients. Huntsman Cancer Center is ...
Overview: Pharma Mar, S.A. is a biopharmaceutical company ... Revenue growth is also expected to be robust at 23.2% per year, surpassing market averages.
The Indian pharma market, currently valued at around USD 55 billion, is projected to expand 2.2 to 2.4 times over the next six years, reaching USD 120 billion to USD 130 billion. Pharma exports FY ...
No wonder some of the leading DIIs in India have placed big bets on these 2 pharma giants. Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished ...
You've probably heard this before: Pharmaceutical stocks can bring an ... Rinvoq and Skyrizi sales rose 45% to $1.6 billion and 50% to $3.2 billion, respectively. AbbVie also has an impressive ...
The new plan, which has been dubbed a “strategic productivity initiative,” will slash $2 billion in costs by the ... BMS is not the only U.S. pharma giant making massive cuts.
Cairo, Egypt: Fawry (the "Company", FWRY.CA on the Egyptian Exchange), Egypt's leading e-payments solutions provider, announced a strategic partnership with PharmaOverseas, to deliver innovative ...
The success of their audacious strategy paves the way for charities and not-for-profits to bring drugs to market for diseases that are neglected by big pharmaceutical ... about $2.4 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results